- Home
- NERV vs ISPC Comparison
NERV vs ISPC Comparison
Compare NERV & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- ISPC
- Stock Information
- Founded
- NERV 2007
- ISPC 2009
- Country
- NERV United States
- ISPC United States
- Employees
- NERV N/A
- ISPC 24
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- NERV Health Care
- ISPC Health Care
- Exchange
- NERV Nasdaq
- ISPC Nasdaq
- Market Cap
- NERV 12.0M
- ISPC 13.9M
- IPO Year
- NERV 2014
- ISPC 2021
- Fundamental
- Price
- NERV $2.15
- ISPC $1.55
- Analyst Decision
- NERV Hold
- ISPC
- Analyst Count
- NERV 1
- ISPC 0
- Target Price
- NERV $5.00
- ISPC N/A
- AVG Volume (30 Days)
- NERV 12.9K
- ISPC 20.3M
- Earning Date
- NERV 11-04-2025
- ISPC 11-06-2025
- Dividend Yield
- NERV N/A
- ISPC N/A
- EPS Growth
- NERV N/A
- ISPC N/A
- EPS
- NERV 1.48
- ISPC N/A
- Revenue
- NERV N/A
- ISPC $5,908,088.00
- Revenue This Year
- NERV N/A
- ISPC $35.93
- Revenue Next Year
- NERV N/A
- ISPC N/A
- P/E Ratio
- NERV $1.46
- ISPC N/A
- Revenue Growth
- NERV N/A
- ISPC N/A
- 52 Week Low
- NERV $1.15
- ISPC $0.64
- 52 Week High
- NERV $2.98
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- NERV 48.19
- ISPC 56.46
- Support Level
- NERV $2.06
- ISPC $1.47
- Resistance Level
- NERV $2.25
- ISPC $2.58
- Average True Range (ATR)
- NERV 0.11
- ISPC 0.46
- MACD
- NERV -0.03
- ISPC 0.08
- Stochastic Oscillator
- NERV 24.19
- ISPC 35.63
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.